[Newer aspects in the therapy of angina pectoris].
Progress in coronary surgery has led to new aspects in the treatment of angina pectoris. According to the coronar-angiographic findings, which make an exact identification of the coronary heart disease possible, and according to the ventricular function a therapeutic strategy can be determined today with adequate safety for each individual case. The most important criterium for a decision for surgical or conservative treatment is not only the improvement of the subjective symptoms, in special forms of coronary heart disease the bypass-operation not only results in improved quality of life but also in a considerably increased survival time.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000601:surgery; D002118:Calcium / Q000037:antagonists & inhibitors; D001026:Coronary Artery Bypass; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D005996:Nitroglycerin; D002118:Calcium
Neuere Aspekte in der Therapie der Angina pectoris